Recombinant neuregulin 1 does not activate cardiomyocyte DNA synthesis in normal or infarcted adult mice

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Reuter, Sean ^a   Soonpaa, Mark H ^a   Firulli, Anthony B ^a   Chang, Audrey N ^b   Field, Loren J ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MYOSIN HEAVY CHAIN BETA; RECOMBINANT NEUREGULIN 1BETA1; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; DNA; NEU DIFFERENTIATION FACTOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR PARAMETERS; CELL CYCLE ARREST; CELL PROLIFERATION; CELL RENEWAL; CONTROLLED STUDY; CORONARY ARTERY OCCLUSION; DNA SYNTHESIS; ENZYME ACTIVATION; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CELL; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; TISSUE REGENERATION; ANIMAL; BIOSYNTHESIS; DBA MOUSE; DNA REPLICATION; DRUG EFFECTS; METABOLISM; MYOCARDIAL INFARCTION; TRANSGENIC MOUSE;

MUS;

ANIMALS; DNA; DNA REPLICATION; MICE, INBRED DBA; MICE, TRANSGENIC; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; NEUREGULIN-1; RECOMBINANT PROTEINS;

EID: 84920087867     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0115871     Document Type: Article

References (52)

1. Soonpaa MH, Field LJ (1998) Survey of studies examining mammalian cardiomyocyte DNA synthesis. Circ Res 83: 15-26.
2. Soonpaa MH, Rubart M, Field LJ (2013) Challenges measuring cardiomyocyte renewal. Biochim Biophys Acta 1833: 799-803.
3. Esper RM, Pankonin MS, Loeb JA (2006) Neuregulins: versatile growth and differentiation factors in nervous system development and human disease. Brain Res Rev 51: 161-175.
4. Falls DL (2003) Neuregulins: functions, forms, and signaling strategies. Exp Cell Res 284: 14-30.
5. Fuller SJ, Sivarajah K, Sugden PH (2008) ErbB receptors, their ligands, and the consequences of their activation and inhibition in the myocardium. J Mol Cell Cardiol 44: 831-854.
6. Lemmens K, Doggen K, De Keulenaer GW (2007) Role of neuregulin-1/ErbB signaling in cardiovascular physiology and disease: implications for therapy of heart failure. Circulation 116: 954-960.
7. Marguerie A, Bajolle F, Zaffran S, Brown NA, Dickson C, et al. (2006) Congenital heart defects in Fgfr2-IIIb and Fgf10 mutant mice. Cardiovasc Res 71: 50-60.
8. Meyer D, Birchmeier C (1995) Multiple essential functions of neuregulin in development. Nature 378: 386-390.
9. Gassmann M, Casagranda F, Orioli D, Simon H, Lai C, et al. (1995) Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature 378: 390-394.
10. Lee KF, Simon H, Chen H, Bates B, Hung MC, et al. (1995) Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature 378: 394-398.
11. Engel FB, Schebesta M, Duong MT, Lu G, Ren S, et al. (2005) p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes Dev 19: 1175-1187.
12. Zhao YY, Sawyer DR, Baliga RR, Opel DJ, Han X, et al. (1998) Neuregulins promote survival and growth of cardiac myocytes. Persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytes. J Biol Chem 273: 10261-10269.
13. Grego-Bessa J, Luna-Zurita L, del Monte G, Bolos V, Melgar P, et al. (2007) Notch signaling is essential for ventricular chamber development. Dev Cell 12: 415-429.
14. Braun T, Dimmeler S (2009) Breaking the silence: stimulating proliferation of adult cardiomyocytes. Dev Cell 17: 151-153.
15. Odiete O, Hill MF, Sawyer DB (2012) Neuregulin in cardiovascular development and disease. Circ Res 111: 1376-1385.
16. Ozcelik C, Erdmann B, Pilz B, Wettschureck N, Britsch S, et al. (2002) Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy. Proc Natl Acad Sci U S A 99: 8880-8885.
17. Garcia-Rivello H, Taranda J, Said M, Cabeza-Meckert P, Vila-Petroff M, et al. (2005) Dilated cardiomyopathy in Erb-b4-deficient ventricular muscle. Am J Physiol Heart Circ Physiol 289: H1153-1160.
18. Rohrbach S, Yan X, Weinberg EO, Hasan F, Bartunek J, et al. (1999) Neuregulin in cardiac hypertrophy in rats with aortic stenosis. Differential expression of erbB2 and erbB4 receptors. Circulation 100: 407-412.
19. Rohrbach S, Niemann B, Silber RE, Holtz J (2005) Neuregulin receptors erbB2 and erbB4 in failing human myocardium - depressed expression and attenuated activation. Basic Res Cardiol 100: 240-249.
20. Uray IP, Connelly JH, Thomazy V, Shipley GL, Vaughn WK, et al. (2002) Left ventricular unloading alters receptor tyrosine kinase expression in the failing human heart. J Heart Lung Transplant 21: 771-782.
21. Geiger S, Lange V, Suhl P, Heinemann V, Stemmler HJ. Anticancer therapy induced cardiotoxicity: review of the literature. Anticancer Drugs 21: 578-590.
22. De Keulenaer GW, Doggen K, Lemmens K. The vulnerability of the heart as a pluricellular paracrine organ: lessons from unexpected triggers of heart failure in targeted ErbB2 anticancer therapy. Circ Res 106: 35-46.
23. Gu X, Liu X, Xu D, Li X, Yan M, et al. Cardiac functional improvement in rats with myocardial infarction by up-regulating cardiac myosin light chain kinase with neuregulin. Cardiovasc Res 88: 334-343.
24. Kuramochi Y, Guo X, Sawyer DB (2006) Neuregulin activates erbB2-dependent src/FAK signaling and cytoskeletal remodeling in isolated adult rat cardiac myocytes. J Mol Cell Cardiol 41: 228-235.
25. Giraud MN, Fluck M, Zuppinger C, Suter TM (2005) Expressional reprogramming of survival pathways in rat cardiocytes by neuregulin-1beta. J Appl Physiol 99: 313-322.
26. Kuramochi Y, Cote GM, Guo X, Lebrasseur NK, Cui L, et al. (2004) Cardiac endothelial cells regulate reactive oxygen species-induced cardiomyocyte apoptosis through neuregulin-1beta/erbB4 signaling. J Biol Chem 279: 51141-51147.
27. Fukazawa R, Miller TA, Kuramochi Y, Frantz S, Kim YD, et al. (2003) Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt. J Mol Cell Cardiol 35: 1473-1479.
28. Baliga RR, Pimental DR, Zhao YY, Simmons WW, Marchionni MA, et al. (1999) NRG-1-induced cardiomyocyte hypertrophy. Role of PI-3-kinase, p70(S6K), and MEK-MAPK-RSK. Am J Physiol 277: H2026-2037.
29. Bian Y, Sun M, Silver M, Ho KK, Marchionni MA, et al. (2009) Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins. Am J Physiol Heart Circ Physiol 297: H1974-1983.
30. Timolati F, Ott D, Pentassuglia L, Giraud MN, Perriard JC, et al. (2006) Neuregulin-1 beta attenuates doxorubicin-induced alterations of excitation-contraction coupling and reduces oxidative stress in adult rat cardiomyocytes. J Mol Cell Cardiol 41: 845-854.
31. Liu X, Gu X, Li Z, Li X, Li H, et al. (2006) Neuregulin-1/erbB-activation improves cardiac function and survival in models of ischemic, dilated, and viral cardiomyopathy. J Am Coll Cardiol 48: 1438-1447.
32. Gao R, Zhang J, Cheng L, Wu X, Dong W, et al. A Phase II, randomized, double-blind, multicenter, based on standard therapy, placebo-controlled study of the efficacy and safety of recombinant human neuregulin-1 in patients with chronic heart failure. J Am Coll Cardiol 55: 1907-1914.
33. Jabbour A, Hayward CS, Keogh AM, Kotlyar E, McCrohon JA, et al. Parenteral administration of recombinant human neuregulin-1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses. Eur J Heart Fail 13: 83-92.
34. Bersell K, Arab S, Haring B, Kuhn B (2009) Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell 138: 257-270.
35. Formiga FR, Pelacho B, Garbayo E, Imbuluzqueta I, Diaz-Herraez P, et al. (2013) Controlled delivery of fibroblast growth factor-1 and neuregulin-1 from biodegradable microparticles promotes cardiac repair in a rat myocardial infarction model through activation of endogenous regeneration. J Control Release.
36. Ang KL, Shenje LT, Reuter S, Soonpaa MH, Rubart M, et al. (2010) Limitations of conventional approaches to identify myocyte nuclei in histologic sections of the heart. Am J Physiol Cell Physiol 298: C1603-1609.
37. Soonpaa MH, Koh GY, Klug MG, Field LJ (1994) Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science 264: 98-101.
38. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, et al. (2004) Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428: 664-668.
39. Soonpaa MH, Field LJ (1994) Assessment of cardiomyocyte DNA synthesis during hypertrophy in adult mice. Am J Physiol 266: H1439-1445.
40. Junqueira LCU, Carneiro J, Kelley RO (1992) Basic histology. Norwalk, Conn.: Appleton & Lange. x, 518 p.
41. Soonpaa MH, Field LJ (1997) Assessment of cardiomyocyte DNA synthesis in normal and injured adult mouse hearts. Am J Physiol 272: H220-226.
42. Nakajima H, Nakajima HO, Tsai SC, Field LJ (2004) Expression of mutant p193 and p53 permits cardiomyocyte cell cycle reentry after myocardial infarction in transgenic mice. Circ Res 94: 1606-1614.
43. Chang AN, Huang J, Battiprolu PK, Hill JA, Kamm KE, et al. (2013) The effects of neuregulin on cardiac Myosin light chain kinase gene-ablated hearts. PLoS One 8: e66720.
44. Creamer B, Shorter RG, Bamforth J (1961) The turnover and shedding of epithelial cells. I. The turnover in the gastro-intestinal tract. Gut 2: 110-118.
45. Senyo SE, Steinhauser ML, Pizzimenti CL, Yang VK, Cai L, et al. (2013) Mammalian heart renewal by pre-existing cardiomyocytes. Nature 493: 433-436.
46. Angert D, Berretta RM, Kubo H, Zhang H, Chen X, et al. (2011) Repair of the injured adult heart involves new myocytes potentially derived from resident cardiac stem cells. Circ Res 108: 1226-1237.
47. Koh GY, Soonpaa MH, Klug MG, Pride HP, Cooper BJ, et al. (1995) Stable fetal cardiomyocyte grafts in the hearts of dystrophic mice and dogs. J Clin Invest 96: 2034-2042.
48. Nakajima H, Nakajima HO, Dembowsky K, Pasumarthi KB, Field LJ (2006) Cardiomyocyte cell cycle activation ameliorates fibrosis in the atrium. Circ Res 98: 141-148.
49. Nakajima H, Nakajima HO, Salcher O, Dittie AS, Dembowsky K, et al. (2000) Atrial but not ventricular fibrosis in mice expressing a mutant transforming growth factor-beta(1) transgene in the heart. Circ Res 86: 571-579.
50. Pasumarthi KB, Nakajima H, Nakajima HO, Jing S, Field LJ (2000) Enhanced cardiomyocyte DNA synthesis during myocardial hypertrophy in mice expressing a modified TSC2 transgene. Circ Res 86: 1069-1077.
51. Pasumarthi KB, Nakajima H, Nakajima HO, Soonpaa MH, Field LJ (2005) Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice. Circ Res 96: 110-118.
52. Soonpaa MH, Koh GY, Pajak L, Jing S, Wang H, et al. (1997) Cyclin D1 overexpression promotes cardiomyocyte DNA synthesis and multinucleation in transgenic mice. J Clin Invest 99: 2644-2654.